These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31244948)

  • 1. Polyphenol-Based Particles for Theranostics.
    Dai Q; Geng H; Yu Q; Hao J; Cui J
    Theranostics; 2019; 9(11):3170-3190. PubMed ID: 31244948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineering of Metal-organic Frameworks for Nanomedicine.
    Liu Y; Zhao Y; Chen X
    Theranostics; 2019; 9(11):3122-3133. PubMed ID: 31244945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Developments of Supramolecular Metal-based Structures for Applications in Cancer Therapy and Imaging.
    Pöthig A; Casini A
    Theranostics; 2019; 9(11):3150-3169. PubMed ID: 31244947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal-Organic Framework Nanoparticle-Based Biomineralization: A New Strategy toward Cancer Treatment.
    Chu C; Su M; Zhu J; Li D; Cheng H; Chen X; Liu G
    Theranostics; 2019; 9(11):3134-3149. PubMed ID: 31244946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus particles: recent advances in the biomedical applications.
    Le TC; Zhai J; Chiu WH; Tran PA; Tran N
    Int J Nanomedicine; 2019; 14():6749-6777. PubMed ID: 31692550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphenol-Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery.
    Guo Y; Sun Q; Wu FG; Dai Y; Chen X
    Adv Mater; 2021 Jun; 33(22):e2007356. PubMed ID: 33876449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
    Mehata AK; Vikas ; Viswanadh MK; Muthu MS
    Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-supramolecule conjugates in theranostics.
    Chen K; Fu T; Sun W; Huang Q; Zhang P; Zhao Z; Zhang X; Tan W
    Theranostics; 2019; 9(11):3262-3279. PubMed ID: 31244953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-organic Nanopharmaceuticals.
    Steinborn B; Lächelt U
    Pharm Nanotechnol; 2020; 8(3):163-190. PubMed ID: 32316907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphenol-Mediated Assembly for Particle Engineering.
    Zhou J; Lin Z; Ju Y; Rahim MA; Richardson JJ; Caruso F
    Acc Chem Res; 2020 Jul; 53(7):1269-1278. PubMed ID: 32567830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
    Yang S; Li D; Chen L; Zhou X; Fu L; You Y; You Z; Kang L; Li M; He C
    Biomater Sci; 2021 May; 9(9):3306-3318. PubMed ID: 33459315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-modulated self-assembly as a versatile strategy for tumor supramolecular nanotheranostics.
    Li S; Zou Q; Xing R; Govindaraju T; Fakhrullin R; Yan X
    Theranostics; 2019; 9(11):3249-3261. PubMed ID: 31244952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-phenolic networks for cancer theranostics.
    Liu P; Shi X; Zhong S; Peng Y; Qi Y; Ding J; Zhou W
    Biomater Sci; 2021 Apr; 9(8):2825-2849. PubMed ID: 33688863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Organic-Inorganic Nanogels for Activatable Theranostics.
    Li F; Liang Z; Ling D
    Curr Med Chem; 2019; 26(8):1366-1376. PubMed ID: 28933302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-phenolic networks: facile assembled complexes for cancer theranostics.
    Xie W; Guo Z; Zhao L; Wei Y
    Theranostics; 2021; 11(13):6407-6426. PubMed ID: 33995665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of Biomolecular Templates for Synthesizing Multifunctional Noble Metal Nanoclusters toward Personalized Theranostic Applications.
    Yu Y; Mok BY; Loh XJ; Tan YN
    Adv Healthc Mater; 2016 Aug; 5(15):1844-59. PubMed ID: 27377035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.